E7107

DB12508InvestigationalSmall molecule

E7107 has been used in trials studying the treatment of Cancer.

Mechanism: Pharmacologically active on Splicing factor 3B subunit 3, Splicing factor 3B subunit 1, and PHD finger-like domain-containing protein 5A
Curator reviewed
Formula / weight: C₄₀H₆₆N₂O₉ · 718.973 g/mol (avg)

Resolves to

Compound

Structure

CC[C@H](O)[C@@H](C)[C@H]1O[C@@H]1C[C@@](C)(O)\C=C\C=C(/C)[C@H]1OC(=O)C[C@H](O)CC[C@@](C)(O)[C@@H](OC(=O)N2CCN(CC2)C2CCCCCC2)\C=C\[C@@H]1C

Targets

What you can answer from here — as of July 07, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with E7107, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.